CLINICAL_TRIALS
trial_result
· 2011-08-26
Clinical Trial Update: Aralast alpha1-proteinase Inhibitor Surveillance Study [Phase 4]
Summary
A Phase 4 surveillance study of Aralast alpha1-proteinase inhibitor in Alpha1-antitrypsin Deficiency was terminated with results posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Baxalta now part of Shire | Conditions: Alpha1-antitrypsin Deficiency | Phase 4 | Status: TERMINATED | Results posted: 2011-08-26